Related Experiment Videos
[Molecular genetics of mood disorders]
Masashi Ikeda1, Tsuyoshi Kitajima, Nakao Iwata
1Department of Psychiatry, Fujita Health University School of Medicine, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192 Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|November 28, 2002
Summary
Genetic factors play a key role in mood disorders. Molecular genetics research aims to identify susceptible genes for better prevention and treatment strategies.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Context:
- Mood disorders represent a significant societal burden, with many cases proving resistant to current treatments.
- Understanding the underlying pathophysiology is crucial for developing effective prevention and therapeutic interventions.
Purpose:
- To review the current state of molecular genetics research in mood disorders.
- To highlight key findings from linkage and association studies.
- To discuss the role of pharmacogenetics in personalized medicine for mood disorders.
Summary:
- Genetic epidemiological studies confirm a substantial genetic contribution to mood disorders.
- Linkage studies have identified several chromosomal regions associated with mood disorders (e.g., 1q21-42, 4p16).
- Association studies have primarily focused on neurotransmitter systems, including serotonin and dopamine pathways, and related enzymes (e.g., COMT, MAO-A).
- Pharmacogenetic studies are exploring genetic variations to guide drug development and personalize treatment approaches.
Impact:
- Advances in molecular genetics are expected to identify specific genes contributing to mood disorder susceptibility.
- This knowledge will pave the way for novel diagnostic tools, targeted therapies, and personalized medicine strategies.
- Ultimately, identifying susceptible genes will facilitate the true prevention and treatment of mood disorders.